Literature DB >> 1987201

Intracranial meningiomas: correlation between MR imaging and histology in fifty patients.

P Demaerel1, G Wilms, M Lammens, G Marchal, C Plets, J Goffin, A L Baert.   

Abstract

The magnetic resonance (MR) findings in 50 surgically verified intracranial meningiomas were reviewed. An attempt was made to correlate their signal intensity on spin echo (SE) T1-weighted, proton density [N(H)], and T2-weighted images with the different histologic subtypes. The T1-weighted images were nonspecific in differentiating the subtypes of meningiomas. On proton density and T2-weighted images, more information was available, but there remained large group (46%) of meningiomas that were not classifiable. The average signal intensity scores on T1-weighted, proton density, and T2-weighted images in the different histologic subtypes were correlated with each other using the Student t test. Only one significant correlation (psammomatous-anaplastic) and three almost significant correlations (syncytial-transitional or psammomatous and transitional-psammomatous) were found. Different histologic subtypes may have a different MR appearance, but this does not suffice to reach a histologic diagnosis by MR imaging.

Entities:  

Mesh:

Year:  1991        PMID: 1987201

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  12 in total

1.  Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings.

Authors:  C G Filippi; M A Edgar; A M Uluğ; J C Prowda; L A Heier; R D Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 2.  Can MRI predict meningioma consistency?: a correlation with tumor pathology and systematic review.

Authors:  Amy Yao; Margaret Pain; Priti Balchandani; Raj K Shrivastava
Journal:  Neurosurg Rev       Date:  2016-11-21       Impact factor: 3.042

3.  Dural attachment of intracranial meningiomas: evaluation with contrast-enhanced three-dimensional fast imaging with steady-state acquisition (FIESTA) at 3 T.

Authors:  Junkoh Yamamoto; Shingo Kakeda; Mayu Takahashi; Yuichi Aoyama; Yoshiteru Soejima; Takeshi Saito; Daisuke Akiba; Yukunori Korogi; Shigeru Nishizawa
Journal:  Neuroradiology       Date:  2010-07-29       Impact factor: 2.804

4.  Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas.

Authors:  E Tedeschi; A Soricelli; A Brunetti; M Romano; A Bucciero; G Iaconetta; A Alfieri; A Postiglione; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-11

5.  Radiology of meningiomas.

Authors:  L E Ginsberg
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

6.  MRI of intracranial meningiomas: correlations with histology and physical consistency.

Authors:  P Carpeggiani; G Crisi; C Trevisan
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

7.  Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging.

Authors:  C-H Toh; M Castillo; A M-C Wong; K-C Wei; H-F Wong; S-H Ng; Y-L Wan
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

8.  Meningiomas: correlation between MRI characteristics and operative findings including consistency.

Authors:  Y Suzuki; T Sugimoto; M Shibuya; K Sugita; S J Patel
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up.

Authors:  Faruk Ildan; Tahsin Erman; A Iskender Göçer; Metin Tuna; Hüseyin Bağdatoğlu; Erdal Cetinalp; Refik Burgut
Journal:  Skull Base       Date:  2007-05

10.  Differentiation of benign angiomatous and microcystic meningiomas with extensive peritumoral edema from high grade meningiomas with aid of diffusion weighted MRI.

Authors:  Avetis Azizyan; Paula Eboli; Doniel Drazin; James Mirocha; Marcel M Maya; Serguei Bannykh
Journal:  Biomed Res Int       Date:  2014-11-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.